LY-411575: Applied Gamma-Secretase Inhibitor Workflows in Re
2026-06-19
LY-411575 stands out as a potent gamma-secretase inhibitor, enabling precise modulation of amyloid beta and Notch signaling in both Alzheimer's and cancer research. This article delivers actionable workflow enhancements, troubleshooting strategies, and a critical review of applied use-cases, bridging protocol reliability with the latest evidence.
Gene Expression Profiling Reveals Olaparib Sensitivity in MP
2026-06-19
Borchert et al. (2019) identified homologous recombination repair (HRR) defects—termed 'BRCAness'—in malignant pleural mesothelioma (MPM) and linked these to increased susceptibility to PARP inhibition with olaparib. Their findings suggest a path towards more personalized therapeutic strategies and highlight the complexity underlying chemoresistance in MPM.
Sodium Nitroprusside in Vascular Research: Workflow & Troubl
2026-06-18
Sodium Nitroprusside stands out as a potent nitric oxide donor for dissecting vascular smooth muscle relaxation and platelet aggregation inhibition. This guide translates recent sex-difference hypertension models into actionable workflows, troubleshooting, and protocol enhancements for maximizing reproducibility in preclinical vascular studies.
Luminescent ATP Cell Viability Assay Kit I: Precision in Fer
2026-06-18
The Luminescent ATP Cell Viability Assay Kit I empowers researchers to dissect regulated cell death, such as ferroptosis, with unrivaled sensitivity and speed. By leveraging luciferase luminescence detection, this kit streamlines cell viability measurement and supports advanced experimental designs that are essential for modern mechanistic studies.
MLN8237 (Alisertib): Precision Aurora A Inhibition in Cancer
2026-06-17
MLN8237 (Alisertib) provides scientists with a best-in-class tool for dissecting Aurora A kinase-driven oncogenesis, enabling robust apoptosis induction and tumor growth inhibition in laboratory models. Discover reproducible workflows, troubleshooting insights, and the translational edge of targeting AURKA in high-risk cancers, as validated by recent landmark studies.
Intravesical p21 mRNA-LNP Therapy: Mechanistic Insights in B
2026-06-17
This article examines a 2026 reference study on intravesical delivery of p21 mRNA–loaded lipid nanoparticles (LNPs) for tumor suppressor replacement in bladder cancer. The research demonstrates that local administration of p21 mRNA-LNPs restores p21 expression, suppresses tumor growth, and preserves bladder tissue architecture, supporting the clinical translation of mRNA therapeutics for localized cancer treatment.
Capecitabine in Preclinical Oncology: Protocols & Pitfalls
2026-06-16
Capecitabine’s tumor-selective activation and robust apoptosis induction make it a gold standard for tumor-targeted drug delivery research. This guide translates breakthrough assembloid modeling into actionable workflows, troubleshooting, and optimization tips for bench scientists leveraging Capecitabine from APExBIO.
ATRX-Deficient Glioma Sensitivity to RTK and PDGFR Inhibitor
2026-06-16
The reference study demonstrates that high-grade glioma cells lacking functional ATRX exhibit heightened sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. These findings provide a rationale for incorporating ATRX mutation status into clinical trial analyses and therapeutic strategies targeting angiogenesis and tumor growth in glioma.
Ketone Body-Induced Ferroptosis Inhibition in Stroke Neuropr
2026-06-15
This study demonstrates that remote ischemic postconditioning (RIPostC) offers neuroprotection after stroke by promoting ketone body-mediated inhibition of ferroptosis. These findings highlight a novel energy metabolism-linked mechanism that may inform future strategies for ischemic brain injury intervention.
ECL Western Blotting Substrate: Practical Use and Workflow G
2026-06-15
ECL Western Blotting Substrate provides a sensitive, nonradioactive solution for detecting horseradish peroxidase (HRP) in Western blot assays. It is best suited for protein detection by chemiluminescence in molecular biology, cancer biology, and signal transduction pathway research, and is not intended for fluorescent or radioisotopic detection workflows.
Geneticin, G-418 Sulfate: Selection and Antiviral Protocol G
2026-06-14
Geneticin, G-418 Sulfate provides reliable selective pressure for isolation and maintenance of eukaryotic cells expressing the neomycin resistance gene, and also supports antiviral studies targeting Dengue virus serotype 2. It is not suitable for experiments requiring ethanol or DMSO solubilization, or for use in systems lacking the appropriate resistance marker.
Cell Senescence β-Galactosidase Staining Kit: Workflow & Ins
2026-06-13
The Cell Senescence β-Galactosidase Staining Kit stands out for its artifact-free, high-specificity detection of senescent cells—empowering robust workflows in aging and drug discovery research. This guide translates experimental breakthroughs into optimized protocols, troubleshooting, and practical enhancements tailored for advanced senescence assays.
RNA Pol II Loss Triggers Active Apoptosis Independent of Tra
2026-06-12
Harper et al. (2025) demonstrate that inhibition of RNA polymerase II (Pol II) induces apoptosis through an active signaling pathway, independent of global transcriptional shutdown. This finding redefines how cell death is initiated in response to transcriptional perturbation and has broad implications for targeting apoptotic mechanisms in cancer biology.
Optimizing Cancer Research with VE-822 ATR Inhibitor (SKU B1
2026-06-12
This article addresses real-world experimental challenges in cell viability and cytotoxicity assays, with an emphasis on reliable DNA damage response inhibition using VE-822 (SKU B1383). Drawing on quantitative data, evidence-backed protocols, and comparative vendor analysis, we outline best practices for leveraging VE-822 in translational cancer and iPSC-based research. Researchers will find actionable guidance for protocol optimization and product selection.
Tropisetron Hydrochloride: Precision 5-HT3 Receptor Antagoni
2026-06-11
Tropisetron Hydrochloride empowers researchers with selective 5-HT3 receptor antagonism and α7-nicotinic receptor agonism, enabling advanced serotonin receptor signaling studies. This article details practical workflows, protocol enhancements, and troubleshooting insights that leverage APExBIO’s high-purity standard for reproducible neuroscience and transporter interaction research.
466 records 15/32 page Previous Next First page 上5页 1112131415 下5页 Last page